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Review article
Ανασκόπηση
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   Βασικές αρχές της κυτταρολογικής εξέτασης του μυελού των οστών στο 
σκύλο και τη γάτα
Μυλωνάκης Μ.Ε.1, Χατζής Α.2
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ABSTRACT 
In companion animal medicine, bone marrow (BM) aspiration cytology is a cost-effective diagnostic tool, which provides 
excellent morphological detail of cells and infectious agents. The major indications for BM aspiration include unexplained clin-
ical manifestations (e.g., fever, body weight loss), persistent hematological or biochemical abnormalities (e.g., anemia, leuko-
cytosis), diagnosis and/or staging of malignancies (e.g., lymphoma, mast-cell tumor), diagnosis of important infectious diseases 
such as leishmaniosis (Leishmania infantum) and canine monocytic ehrlichiosis (Ehrlichia canis) and evaluation of canine iron 
stores. Complications associated with BM aspiration are rare and the equipment and supplies required minimal, hence account-
ing for the popularity of this procedure in the clinical setting compared to BM core biopsy. This review focuses on the techni-
cal details pertaining to the collection of BM aspirate material, including the usual anatomic sites for sampling, the equipment 
required, the preparation of the animal, the aspiration technique and the BM material processing for good quality slide prepara-
tion. The description of the cellular population normally anticipated in the BM of the dog and cat and the systematic approach 
in evaluating and interpreting the BM cytological findings are also highlighted. In the last part of this review, the current clas-
sification guidelines for the canine and feline BM malignancies are briefly outlined.
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INDICATIONS FOR BONE MARROW (BM) 
ASPIRATION
after birth and in health, hematopoiesis is nor-mally confined to BM, which occupies the med-
ullary cavities of trabecular bone (Figure 1). Bone 
marrow comprises of red marrow that contains the 
abundance of hematopoietic cells (active marrow) and 
yellow marrow, predominated by adipose tissue. The 
distribution and relative proportion of red and yel-
low marrow are age dependent. after birth, the BM 
cavity is completely occupied by red marrow. With 
aging, hematopoietic marrow is gradually replaced 
by yellow marrow so that during adulthood, red mar-
row is mainly confined to the vertebr ae, skull, ribs, 
sternum, pelvis and the proximal humeri and femora. 
This trend, however, can change and with increased 
demand and appropriate stimuli hematopoietic tissue 
can expand.
Bone marrow aspiration cytology is a cost-
effective diagnostic tool, providing excellent mor-
phological detail of cells and infectious agents 
(Grindem et al., 2002). Though with BM core biop-
sy, the architectural pattern of tissue is better reflect-
ed, and a range of features including BM cellularity, 
the presence of myelofibrosis and focal inflammatory 
or neoplastic lesions are better appreciated (Raskin 
and Messick, 2012), cellular detail is more difficult 
to assess; the latter along with a slightly more elabo-
rate procedure for obtaining the sample and longer 
processing times might contribute to the fact that, 
in the clinical setting, BM aspirations are more fre-
quently performed compared to core biopsies in the 
dog and cat (Grindem et al., 2002).
Indications for BM examination include hema-
tological abnormalities that cannot be investigated by 
other means, investigation, staging and management 
of hematologic and other neoplasias (e.g., lymphoma, 
ΠΕΡΙΛΗΨΗ 
Η κυτταρολογική εξέταση του μυελού των οστών (ΜΟ) αποτελεί ένα πρακτικό διαγνωστικό εργαλείο στην ιατρική του σκύλου 
και της γάτας, που επιτρέπει τη λεπτομερή μορφολογική εκτίμηση κυττάρων και μικροοργανισμών. Οι κυριότερες ενδείξεις για 
την κυτταρολογική εξέταση του ΜΟ περιλαμβάνουν τη διερεύνηση ασυνήθιστων κλινικών (π.χ. πυρετός, απώλεια σωματικού 
βάρους), αιματολογικών (π.χ. αναιμία, λευκοκυττάρωση) και βιοχημικών διαταραχών, τη διάγνωση και την κλινική σταδιο-
ποίηση νεοπλασμάτων (π.χ. λέμφωμα, μαστοκύττωμα), τη διάγνωση σημαντικών λοιμωδών νοσημάτων όπως της λεϊσμανί-
ωσης (Leishmania infantum) και της μονοκυτταρικής ερλιχίωσης (Ehrlichia canis) του σκύλου, καθώς και την εκτίμηση της 
παρακαταθήκης σιδήρου στο ΜΟ του σκύλου. Η παρακέντηση του ΜΟ είναι πολύ ασφαλής και ο απαιτούμενος εξοπλισμός 
ελάχιστα δαπανηρός, γεγονός που εξηγεί τη μεγαλύτερη συχνότητα με την οποία διενεργείται στην κλινική πράξη σε σχέση με 
την οστεομυελική βιοψία. Στην ανασκόπηση αυτή περιγράφονται οι τεχνικές λεπτομέρειες για την αξιόπιστη συλλογή ΜΟ και 
κυρίως τα συνήθη ανατομικά σημεία για τη δειγματοληψία, ο απαιτούμενος εξοπλισμός, η προετοιμασία του ζώου, η τεχνική 
αναρρόφησης του ΜΟ και η διαδικασία παρασκευής κυτταρολογικών επιχρισμάτων. Ιδιαίτερη έμφαση δίνεται στην περιγραφή 
του φυσιολογικού κυτταρικού πληθυσμού του ΜΟ στο σκύλο και στη γάτα, καθώς και στην οργανωμένη εξέταση και ερμηνεία 
των κυτταρολογικών ευρημάτων. Τέλος, παρουσιάζεται επιγραμματικά η σύγχρονη κυτταρολογική διάκριση των νεοπλασμά-
των του ΜΟ στο σκύλο και στη γάτα. 
Λέξεις ευρετηρίασης: γάτα, κυτταρολογική εξέταση, μυελός των οστών, σκύλος
Figure 1: Bone marrow trephine biopsy of normal bone structure 
showing bony trabeculae and active hematopoietic bone marrow. 
Paraffin embedded, hematoxylin and eosin x 20.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 07/06/2020 15:19:59 |
J HELLENIC VET MED SOC 2014, 65(3)
ΠΕΚΕ 2014, 65(3)
MyLONaKIS M.E., HaTzIS a. 183
Table 1: Decision-making variables for bone marrow (BM) examination in dogs and cats with hematologic abnormalities
From Foucar 2001 (modified)
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mast cells tumors, solid tumors), evaluation of unex-
plained clinical manifestations (e.g., fever of undeter-
mined origin, body weight loss, lameness), evaluation 
of a patient that does not respond to treatment after 
initial diagnosis (e.g., failure of response to therapy 
in a patient diagnosed with immune mediated throm-
bocytopenia (ITP)), response to therapy for patients 
with haemolymphoid neoplasms, diagnosis of dis-
eases such as leishmaniosis (Leishmania infantum) 
and canine monocytic ehrlichiosis (Ehrlichia canis) 
and evaluation of iron stores in the dog (e.g., differ-
entiation of iron deficiency anemia from anemia of 
inflammation) (Foucar, 2001, Mylonakis et al., 2003, 
Mylonakis et al., 2004, Saridomichelakis et al., 2005, 
Raskin and Messick, 2012).
Several variables should be taken into account 
before making the decision to perform BM examina-
tion (Table 1). In conjunction with the clinical his-
tory and other laboratory findings, these include the 
age of the animal, the presence of single or multiple 
hematological abnormalities, the presence of single 
or multi-lineage dysplasia or the detection of blast 
or other abnormal cells in peripheral blood. Marrow 
aspiration is redundant if the underlying cause of the 
abnormality is inferred or known from the history (e.g., 
a chemotherapy session preceding the development of 
neutropenia), the physical examination (e.g., melena 
in an anemic animal) or the blood smear evaluation 
(e.g., regeneration and spherocytosis in an anemic dog, 
Babesia spp. trophozoites in a dog with fever) (Harvey, 
2012a). On the contrary, the presence of blast cells or 
pancytopenia, almost always necessitate BM examina-
tion. In any case of uncertainty, the clinician is advised 
to seek the assistance of a clinical pathologist or a spe-
cialized hematopathologist. Bleeding tendency is not a 
contraindication for BM aspiration if a superficial site 
is sampled and proper hemostatic measures are applied 
(Mylonakis et al., 2004). 
Overall, BM aspiration is a very safe procedure 
with rarely appearing complications. Post-sampling 
tissue injury, hemorrhage, neuropathy or infection 
may occur, but they are avoided if adherence to 
technical details is exercised. The collection of 
BM from the sternum or the ribs bears the risk of 
inadvertently penetrating the thoracic cavity and 
lacerating intra-thoracic organs, especially if material 
is obtained from small-sized dogs (Harvey, 2012a).
SITES, EQUIPMENT AND TECHNIQUE FOR 
BM ASPIRATION  
The most suitable BM aspiration sites in large-
sized dogs include the iliac crest and proximal 
(greater tubercle) humerus, while in small-sized 
dogs and cats the humerus and the proximal (greater 
trochanter) femur are the most accessible (Raskin 
and Messick, 2012). alternatively, it was recently 
shown in healthy anesthetized Beagles that sternal 
BM aspiration with a hypodermic needle was safe, 
providing cytological samples of equivalent qual-
ity to those from humerus or ilium (Defarges et al., 
2013). Historically, aspiration of the proximal rib 
with special aspiration needles (Silverman-type) 
has also been found to provide cytological samples 
of high quality in the dog, although the technique 
was more risky and labor-intensive compared to the 
iliac crest and sternum (Penny and Carlisle, 1970). 
anecdotally, aspiration of the costochondral junc-
tion of the rib with a hypodermic needle in medium-
to-large-sized dogs may also be a safe and practi-
cal technique for obtaining cytological material. a 
combined technique has been recently described and 
evaluated in adult dog cadavers, in which aspiration 
precedes core biopsy but both procedures are done 
with the same needle and at the same site (Reeder 
et al., 2013). although there was no difference in 
cellularity, megakaryocyte count, myeloid/erythroid 
ratio (M/E ratio), iron stores, or the overall diagnos-
tic quality, marrow core length was shorter, hemor-
rhage artifact was more common and the failure rate 
in obtaining diagnostic material was higher using the 
combined technique compared to the standard direct 
core biopsy method (Reeder et al., 2013).
Postmortem BM aspiration should be performed 
within 30 minutes from the animal’s death, as 
cellular degeneration (especially of the myeloid 
184 MyLONaKIS M.E., HaTzIS a.
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area is clipped, surgically scrubbed and infiltrated 
with lidocaine. Sterile gloves are always used by the 
operator. a stab incision is made in the skin with 
a No. 11 scalpel blade. The aspiration needle with 
stylet in place is passed through the skin incision to 
the bone. The needle is then rotated and advanced in 
a clockwise-counterclockwise motion until it is firmly 
embedded into the bone. The stylet is removed, a 
syringe ringed with a few drops of ethylenediamine 
tetra-acetic acid (EDTa) solution (0.1-0.15 ml of 2-5% 
solution) is attached to the needle, and steady negative 
pressure is applied to the plunger (5-7ml vacuum 
pressure) to draw marrow into the syringe. at this 
stage, vocalization is strong evidence that the marrow 
cavity has been sampled. as soon as approximately 
0.5-1 ml of BM aspirate is collected, the pressure on 
the plunger is released and the syringe is removed 
along with the needle. Subsequently, direct pressure is 
applied at the sampling site to minimize bleeding and 
the incision is usually not sutured. If BM collection 
was impossible on the first attempt, the stylet is 
reinserted and the needle is advanced further in the 
bone, and negative pressure is reapplied. If sampling 
is still impossible, the pressure is maintained and the 
needle is slow ly withdrawn, until BM is procured or 
the needle exits the bone. Repeated failures to obtain 
BM, indicates the need for aspirating an adjacent site, 
another bone, or to perform core biopsy.
BM ASPIRATION SAMPLES PROCESSING 
BM aspiration samples should be processed as 
quickly as possible after collection, ideally within 
2 hours; for short-term storage (up to 8 hours), they 
may be kept at room temperature or be refrigerated 
(Raskin and Messick, 2012). Several smear prepara-
tion techniques have been described (Mylonakis et 
al., 2005, Harvey, 2012a). The most commonly used 
is the squash technique: one drop of blood is expelled 
onto a glass slide, the latter is tilted to allow drainage 
of excessive blood and the slide-attached spicules are 
squashed by another perpendicularly-placed slide. 
alternatively, BM aspirate material is expelled into 
lineage) begins rapidly after death, and the overall 
quality of the aspirate tends to be poor (Harvey 
2012a, Grindem et al., 2014). Ideally, in an animal 
planned to be euthanized, BM aspiration should be 
done prior to the administration of the euthanasia 
solution (Harvey 2012a). If a delay is anticipated 
until postmortem aspiration, the cadaver is placed 
under refrigeration but not freezing (Raskin and 
Messick, 2012).
Equipment and supplies for BM aspiration 
are minimal (Figure 2). Mild to moderate pain 
is experienced during the BM aspiration procedure 
(Guillot et al., 2011); therefore, sedation (e.g., 
butorphanol [0.2 mg/Kg] and acetylpromazine [40-
50 μg/Kg] in one syringe, intramuscularly) may be 
required in uncooperative animals. In the majority 
of clinical canine and feline cases, local anesthesia 
(infiltration of subcutaneous and subperiosteal tissues 
with lidocaine 2% [1ml/10 Kg]) normally suffices for 
the procedure. admixing lidocaine with bicarbonate 
(9/1 parts, i.e., 45 ml lidocaine with 5 ml bicarbonate), 
minimizes the pain induced by lidocaine infiltration 
itself. The authors apply the following aspiration 
procedure: the patient is placed in a position that 
facilitates access to the aspiration site (e.g., lateral 
position for the humerus and proximal femur, and 
standing or sitting position for the iliac crest). The 
MyLONaKIS M.E., HaTzIS a. 185
Figure 2: Equipment and supplies for bone marrow (BM) 
aspiration: aspiration needle (15-gauge, Illinois-type), 2% lidocaine 
solution, 10-ml syringe ringed with 0.15 ml of 2-3% EDTa solution, 
microscope slides, scalpel blade No. 11, EDTa tube for BM storage, 
sterile gloves, antiseptic soap preparation.
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cytes are smaller than the prorubricytes, have a blue 
cytoplasm, lower N:C ratio and a very heterogeneous 
chromatin pattern (dark and light areas). The poly-
chromatophilic rubricytes have reddish-blue cyto-
plasm, are slightly smaller than basophilic rubricytes 
and have a more condensed nucleus. The metaru-
bricytes feature a very pyknotic nucleus and a cyto-
plasm that is polychromatophilic or orthochromic 
a Petri dish and several spicules are picked with a 
plastic pipette, transferred to glass slides and squashed 
by a slide or coverslip. The latter technique offers the 
advantage of allowing the clinician to aspirate a larger 
volume of sample increasing the likelihood of a suc-
cessful aspiration procedure, since it helps decrease 
the effect of blood contamination during the selec-
tion and smearing process.  Once several smears have 
been prepared, they are subject to rapid air-drying, 
and stained with a Romanowsky-type stain such as 
Giemsa, Wright-Giemsa and Diff-Quik (Mylonakis 
et al., 2005), usually requiring longer staining times 
compared to regular blood smears (usually 2 staining 
cycles for automated stainers). additional stains, such 
as Pearls’ stain for iron, Periodic acid–Schiff (PaS) 
for fungi, can be performed on an individual basis. 
Smears containing adequate BM material will have 
deep blue-staining material on them. Submission to a 
diagnostic laboratory should ideally include numerous 
stained and unstained, unfixed slides.
NORMAL MARROW CELL POPULATION 
The recognition of the cells normally appear-
ing in the BM and their expected reference ranges is 
essential for the proper cytological evaluation of BM 
in diseased dogs and cats.
Erythrocytic lineage
The consecutive developmental stages of the 
erythrocytic (erythroid) cells include the rubriblasts, 
prorubricytes, rubricytes (basophilic and polychro-
matophilic), metarubricytes, and the polychro-
matophilic and mature erythrocytes (Figures 3-5) 
(Harvey, 2012a).
The rubriblasts have an almost perfectly round 
nucleus, with fine chromatin pattern and one or 
two visible nucleoli. The cytoplasm is intensely 
basophilic and this stage has the highest nucleus-to-
cytoplasm (N:C) ratio of the erythroid precursors. 
The prorubricytes have usually no visible nucleoli, 
a slightly less basophilic cytoplasm and a lower N:C 
ratio compared to rubriblasts. The basophilic rubri-
186 MyLONaKIS M.E., HaTzIS a.
Figure 3: Canine bone marrow aspirate: various developmental 
stages of the erythroid series are seen, including rubriblasts (rb), 
prorubricytes (prc), basophilic (br) and polychromatophilic (pr) 
rubricytes and metarubricytes (mr). a few band neutrophils (bn) 
and metamyelocytes (mm) are also present (Giemsa, x1000).
Figure 4: Same dog as in Figure 3. Various developmental stages 
of the erythroid series, including rubriblasts (rb), prorubricytes 
(prc), basophilic (br) and polychromatophilic (pr) rubricytes and a 
metarubricyte (mr). a plasma cell (pc) is also seen at the bottom of 
the field (Giemsa, x1000).
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(red). The polychromatophilic erythrocytes have lost 
their nucleus and they mostly represent reticulocytes 
(stained with supravital stains), eventually forming 
mature erythrocytes. 
Normally, rubriblasts account for less than 5% 
of all erythroid cells in the BM (blast pool), the 
aggregate of prorubricytes and rubricytes for the 
65-75% of all erythroid cells (proliferative pool) 
and metarubricytes for 20-30% of all erythroid cells 
(maturation-storage pool) (Grindem et al., 2014). 
Granulocytic and monocytic lineages
The consecutive developmental stages of the 
granulocytic cells include the myeloblasts, the pro-
granulocytes, the myelocytes, the metamyelocytes, 
the bands and the mature neutrophils (segmented neu-
trophils or segmenters) (Figure 6). The myeloblast, 
the myelocyte and the metamyelocyte stages of the 
granulocytic series cannot reliably be differentiated 
from monocytes (Grindem et al., 2014). 
The myeloblasts are large round cells (overall, 
larger than rubriblasts but smaller than megakaryob-
lasts) with a round to oval nucleus with fine chroma-
tin and one or more visible nucleoli. The cytoplasm 
is less basophilic than that of rubriblasts and this 
stage has the highest nucleus-to-cytoplasm (N:C) 
ratio of the series. Cytoplasmic granules are not usu-
ally observed, but primary (non-specific) granules 
tend to form in late myeloblasts and therefore a few 
(<15) magenta-staining granules may be seen in the 
cytoplasm (Harvey, 2012a). The progranulocytes 
have usually no visible nucleoli and the cytoplasm 
is typically packed with several primary magenta-
staining granules, while the N:C ratio is lower com-
pared to myeloblasts. The myelocytes are smaller than 
progranulocytes and have a round nucleus without 
visible nucleoli. These cells are deprived of primary 
granules, but secondary granules appear at this stage. 
They are not visible in neutrophils due to their neutral 
staining properties, but are easily seen in eosinophils 
and basophils. The metamyelocytes feature a kidney-
shaped nucleus, with indentations extending between 
25% and 75% of the nuclear width and cytoplasmic 
characteristics similar to those of myelocytes. The 
band cells have a curved, rod-shaped nucleus with 
parallel sides and no area with diameter less than 
half the diameter of any other nuclear area. The seg-
mented granulocytes (mature neutrophils, eosinophils 
or basophils) demonstrate a nucleus with two or more 
lobes and areas with intense constrictions.
Normally, myeloblasts account for less than 
5% of all myeloid cells (blast pool), the progranulo-
Figure 6: Various developmental stages of the myeloid series, 
including myeloblasts (mb), myelocytes (mc), metamyelocytes 
(mm), band neutrophils (bn) and segmented neutrophils (sn). Inset: a 
progranulocyte is seen amidst band neutrophils (Diff-Quik, x1000). 
Figure 5: Bone marrow aspirate from a dog with immune-mediated 
hemolytic anemia. Various late developmental stages of the erythroid 
series predominate, including basophilic (br) and polychromatophilic 
(pr) rubricytes and metarubricytes (mr). a small lymphocyte (sl), 
a few band (bn) and segmented (sn) neutrophils, a presumptive 
basophilic rubricyte with fragmented nucleus (fn) and several 
polychromatophilic erythrocytes (pe) are also seen (Giemsa, x1000). 
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nucleated cells. The ploidy level of megakaryocytes 
ranges from 4N (tetraploidy) to 32 N, with the major-
ity of the cells present as 16N (Bain et al., 2010). 
Promegakaryocytes are defined as clearly larger cells 
compared to the erythrocytic or myelocytic precur-
sors that display 2-4 distinct nuclei. Megakaryocytes 
are very large cells (50-200 μm in diameter) featur-
ing a multilobulated nucleus. Based on their cyto-
plasmic characteristics they can be further classified 
into three distinct stages of maturation. Group 1 cells 
display strong cytoplasmic basophilia and a very 
high N:C ratio. Group 2 megakaryocytes display less 
intense staining basophilic cytoplasm, azurophilic 
granulation and a lower N:C ratio. Finally, Group 
3 megakaryocyes feature abundant pale blue stain-
ing cytoplasm and numerous azurophilic granules. 
Overall, the majority of megakaryocytes (>70-80%) 
in BM aspirates are mature (Queisser et al., 1971, 
Mylonakis et al., 2005).  
Lymphocytes and plasma cells
Lymphocytes share a common precursor with 
myeloid cells. The lymphocytes appearing in the 
BM are identical to those in the blood. Small lym-
phocytes predominate, but occasional medium-sized 
or large-sized lymphocytes are seen. In the major-
ity of dogs and cats, lymphocyte percentages do not 
exceed 5-10% of nucleated cells; however, as many 
as 15-20% lymphocytes have been noticed in healthy 
dogs and especially cats (Grindem et al., 2002).
Plasma cells (Figure 4) are normally larger 
than small lymphocytes and feature a round eccen-
tric nucleus and densely basophilic cytoplasm. a 
clear cytoplasmic area adjacent to the nucleus rep-
resenting the Golgi apparatus, further typifies plas-
ma cells. Plasma cells containing round structures 
(Russell bodies) are called Mott cells. Both lym-
phocytes and plasma cells are unevenly distributed 
in the BM, and their percentages may substantially 
differ between different areas, but overall, plasma 
cells do not exceed 2% of BM cells in dogs and cats 
(Grindem et al., 2014).     
cytes plus myelocytes for 15% of all myeloid cells 
(proliferative pool) and the aggregate of metamy-
elocytes, bands and segmenters for 80-85% of all 
myeloid cells (maturation-storage pool) (Grindem et 
al., 2014).
The monocytic series includes the monoblasts, 
promonocytes and monocytes and account for a 
small percentage of the BM cells. Monoblasts cannot 
be differentiated from myeloblasts by light micro-
scopy, although they tend to have a more irregular 
nucleus, while promonocytes are similar to neu-
trophilic myelocytes and metamyelocytes. Monocytes 
are identical to those seen in the blood (Grindem et 
al., 2014).   
Megakaryocytic lineage
The consecutive stages of the megakaryo-
cytic series include the megakaryoblasts, prome-
gakaryocytes, and megakaryocytes (Figure 7). 
Megakaryoblasts are characterized by a single nucle-
us and deeply basophilic cytoplasm, and they are 
hardly differentiated from other blast cells. With 
maturation, megakaryoblasts undergo endoredublica-
tion resulting in the formation of very large multi-
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Figure 7: Megakaryocytic developmental stages in bone 
marrow aspirate smears. a: megakaryoblast (mkb) with single 
nucleous, B: promegakaryocyte (pmkc) with four nuclei, C: 
basophilic megakaryocyte with multiple fused nuclei and an 
intracytoplasmic band neutrophil (bn), D: mature megakaryocyte 
with a cytoplasmic band neutrophil (bn) and two presumptive 
rubricytes (r). Inset of figure 7D: a multinucleated osteoclast is 
visualized (Giemsa, x1000).
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Miscellaneous cells
Macrophages do not normally exceed 2% 
of cells in the BM of dogs and cats. They usually 
display cytoplasmic vacuolation and may contain 
phagocytized material such as nuclar debris, hemo-
siderin and less frequently erythrocytes or leuko-
cytes. Osteoclasts (Figure 7) and osteoblasts are 
occasionally seen in BM aspiration smears espe-
cially in young growing animals. Osteoclasts are 
giant cells with separate multiple nuclei that may 
be confused with megakaryocytes; however, the lat-
ter have fused nuclei. Osteoblasts are reminiscent 
of “large plasma cells”, having an eccentric nucleus 
and foamy basophilic cytoplasm. Mast cells lack-
ing morphological atypia are very rarely seen in the 
BM of healthy dogs accounting for no more than one 
per 1,000 nucleated cells (Mylonakis et al., 2006). 
Vascular and connective tissue cells are uncommonly 
seen and tend to become more apparent in aplastic 
BM when the precursors of the other blood cells are 
depleted. adipocytes are almost always present in 
BM aspirates. Mitotic cells, not always identifiable, 
may account for 2% of nucleated cells in the BM 
(Harvey, 2012a).
EVALUATION AND INTERPRETATION OF 
BM CYTOLOGY
The BM cytological examination should always 
be done in the context of hematological findings 
from a complete blood cell count and peripheral 
blood smear morphologic examination performed 
simultaneously or within hours of BM aspiration. 
a minimum of 3-4 smears should be examined as 
the cellularity can differ between the spicules or 
infiltration by a neoplastic population of cells can 
be patchy. The outcome of the aspiration procedure 
itself may offer some clues towards the overall BM 
quality. as a norm, easily obtained material indi-
cates a normocellular or hypercellular BM, while 
repeated failure to obtain sufficient material (“dry 
taps”) may be due to poor technique, hypocellular or 
fibrotic marrow, or a densely-packed marrow cavity 
(Grindem et al., 2014). a step-by-step cytological 
evaluation of BM is outlined in Table 2.
Low power microscopy 
The evaluation starts on the low power (x10 
objective) for the assessment of smear quality 
(including the selection of areas suitable for high 
power microscopy), BM cellularity, megakaryopoi-
etic activity and the semiquantitation of iron stores. 
High quality smears have numerous well spread out 
BM spicules and several monolayers of intact, well-
stained cells. The cellularity of BM is evaluated by 
estimating the proportion of cells to adipose tissue in 
the flecks (Figures 8 and 9). It is an age-dependent 
Figure 8: Increased bone marrow cellularity in a dog with acute (non 
myelosuppressive) monocytic ehrlichiosis (Ehrlichia canis). Several 
megakaryocytes (mkc) are scattered in the field (Giemsa, x100).
Figure 9: Decreased bone marrow cellularity in a dog with aplastic 
pancytopenia (modified Wright-Giemsa, x200).
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variable with young animals having cellularity as 
high as 75% and aged individuals as low as 25% in 
health. Cellularity varies among smears and between 
flecks; therefore, several smears and flecks should 
be examined to reach a reasonably accurate estima-
tion. Hypocellular BM is usually seen in aplastic 
disorders (e.g., myelosuppressive canine monocytic 
ehrlichiosis, viral feline leukemia, estrogen toxicity) 
or in myelofibrosis (Weiss, 2003). a hypercellular 
BM indicates either erythroid or myeloid hyperpla-
sia, myeloid, lymphoid or metastatic neoplasms, or 
myelodysplasia (Grindem et al., 2014).
Quantitative assessment of megakaryopoiesis 
is largely subjective, due to the relatively low num-
bers and uneven distribution of platelet precursors in 
the BM smears, being more abundant within or near 
the BM particles or the smear edges (Grindem et 
al., 2014). Published normal canine megakaryocyte 
Table 2: Step-by-step evaluation of bone marrow (BM) cytology in the dog and cat
From: Raskin and Messick 2012 (modified)
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numbers vary considerably, mainly due to differ-
ences in smear preparation technique and in the way 
they are quantified (Mylonakis et al., 2005). Overall, 
2–7 cells per spicule, or 2-4 per low-power field in 
squash preparations, represent a likely normal meg-
akaryocyte count (Mylonakis et al., 2005, Silva et al., 
2012, Grindem et al., 2014). More than 10-20 cells per 
low-power field may suggest megakaryocytic hyper-
plasia (Grindem et al., 2014), indicating a regenerative 
thrombocytopenia, usually due to increased destruc-
tion (e.g., immune-mediated thrombocytopenia) or 
utilization (e.g., disseminated intravascular coagula-
tion) of platelets, reactive thrombocytosis (e.g., iron 
deficiency) or essential thrombocythemia. When the 
percentage of mature megakaryocytes is less than 
50%, a regenerative response or a maturation arrest is 
inferred (Grindem et al., 2014). Megakaryocytic hypo-
plasia is usually observed in the context of generalized 
BM suppression (Mylonakis et al., 2004), but uncom-
monly, selective aplasia of the megakaryocytic series 
may be seen, presumably due to immune-mediated 
mechanisms (Lachowicz et al., 2004). Engulfed neu-
trophils or other blood cells may temporarily be found 
overimposed on the cytoplasm of mature megakaryo-
cytes, a phenomenon called emperipolesis (Figure 7). 
The significance of this finding in the dog and cat is 
currently unclear. Dysplastic changes of megakaryo-
cytes (dysmegakaryocytopoiesis) include dwarf meg-
akaryocytes (small megakaryocytes with one or two 
condensed nuclei and mature staining cytoplasm), 
large but hypolobulated or hyperlobulated megakaryo-
cytes, and increased numbers of promegakaryocytes. 
Dysplasia may occur in primary (neoplastic) or sec-
ondary (nonneoplastic) myelodysplastic syndromes 
mainly due to drugs, immune-mediated disease and 
various hematopoietic neoplasms (Harvey, 2012b).
Stainable iron (hemosiderin) may appear with-
in macrophages or extracellularly as gray to black 
aggregates in routinely stained cytological smears 
(Figure 10). Reliable assessment of BM iron stores 
necessitates the use of Prussian blue stain. Unlike 
dogs, healthy cats lack stainable iron in the BM. as 
a rule, diminished iron stores in the dog suggest iron 
deficiency, while increased stores may be associated 
with hemolytic anemia, anemia of chronic disease or 
increased age (Mylonakis et al., 2010, Harvey, 2012a). 
High power microscopy 
Unlike megakaryocytic cells, a thorough mor-
phologic examination of the remaining cell line-
ages, and the estimation of the differential counts and 
myeloid/erythroid ratio (M/E) require the use of x50 
or x100 objectives.
The M/E ratio (also referred to as granulocytic/
erythroid ratio) is calculated by identifying 500 cells 
(originating equally from the marrow flecks and 
inter-fleck areas) as granulocytes (including segment-
ers) or nucleated erythrocytes (Moritz et al., 2010). 
In the clinical setting, subjective estimation of M/E 
ratio usually suffices. In the majority of healthy ani-
mals, the M/E ranges from 0.5 to 3 (Bienzle, 2012, 
Harvey, 2012a, Raskin and Messick, 2012, Grindem 
et al., 2014). The interpretation of the M/E ratio 
should be made in conjunction with marrow cellular-
ity (Grindem et al., 2002).
In healthy dogs and cats, all stages of erythro-
cytic series are represented in the normal propor-
tions, with the vast majority of cells (>80%) being 
in the mature stages (rubricytes and metarubricytes). 
Isolated erythrocytic hyperplasia implies that the 
M/E ratio is decreased, the BM cellularity is normal 
or increased and the neutrophil count in the blood is 
Figure 10: Bone marrow iron stores in a dog with hemolytic 
anemia. Hemosiderin appears as several black globules (arrows) 
(Giemsa, x100).
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normal and may be effective (increasing hematocrit) 
or ineffective (Harvey 2012b). Effective hyperplasia 
usually occurs in hemorrhagic or hemolytic anemias 
(Figure 5), while ineffective hyperplasia may com-
monly appear in chronic iron deficiency anemia and in 
non-regenerative immune-mediated hemolytic anemia 
(Stokol et al., 2000). Isolated erythrocytic hypoplasia 
denotes that the M/E ratio is increased, the BM cel-
lularity is normal or decreased and the neutrophil 
count in the blood is normal or decreased (Harvey, 
2012b). When the M/E ration exceeds 75, pure red 
cell aplasia or selective erythrocytic aplasia is defined 
(Harvey, 2012b). acquired erythrocytic hypoplasia or 
aplasia is usually the result of an immune-mediated 
response that may entirely inhibit the production of 
erythrocytes or result in a maturation arrest at any 
stage of the maturation process (Stokol et al., 2000, 
Harvey, 2012b). It may also be associated with mye-
loid neoplasms, FeLV-infected cats and in a subset 
of animals given recombinant human erythropoi-
etin (Mills, 2012). Dysplastic changes of erythrocytic 
cells (dyserythropoiesis) include increased numbers of 
rubriblasts, megaloblastic cells, multinucleated cells, 
abnormal nuclear shapes or fragmentation (Figure 5), 
nuclear and cytoplasmic asynchrony, maturation arrest 
and siderotic inclusions (Harvey, 2012b). Dysplasia 
may occur in primary (neoplastic) or secondary (non-
neoplastic) myelodysplastic syndromes due to drugs, 
various hematopoietic neoplasms, FeLV-infected cats, 
and in immune-mediated hemolytic anemia (Harvey, 
2012b).
In healthy dogs and cats, all stages of myelo-
cytic series are represented in normal proportions, 
with the vast majority of cells (>80%) being in the 
mature stages (metamyelocytes, bands and segment-
ers). Myelocytic (most commonly neutrophilic) hyper-
plasia implies that the M/E ratio is increased, the BM 
cellularity is normal or increased and the hematocrit 
is normal or increased, and may be effective (accom-
panying blood neutrophilia) or ineffective (persistent 
blood neutropenia) (Harvey, 2012b). Effective hyper-
plasia (Figure 6) usually occurs in bacterial infections, 
immune-mediated diseases, paraneoplastic syndromes, 
early estrogen toxicity and chronic myeloid leukemia 
(Lucroy and Medewell, 1999, Lucroy and Medewell, 
2001). The percentage of myeloblasts is not usu-
ally increased out of proportion, with the exception 
of chronic myeloid leukemia, in which myeloblasts 
may be up to 20% of all nucleated cells (Harvey, 
2012b). Ineffective neutrophilic hyperplasia may com-
monly appear in myelodysplastic syndromes, acute 
myeloid leukemias and FeLV and FIV infections in 
cats. Granulocytic (most commonly neutrophilic) 
hypoplasia denotes that the M/E ratio is decreased, the 
BM cellularity is normal or decreased and the hemat-
ocrit is normal (Harvey, 2012b). Selective neutrophilic 
hypoplasia or aplasia may result from chemotherapy 
drugs, griseofulvin in cats, or occur in a subset of 
Figure 11: a) Canine chronic lymphocytic leukemia. Small 
lymphocytes (sl) account for more than 30% of all nucleated cells 
(Giemsa, x1000). B) Feline small cell lymphoma: small lymphocytes 
efface the bone marrow (modified Wright-Giemsa, x500).
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cases in immune-mediated neutropenia in the dog, 
and parvoviral infections in dogs and cats (Kalli et al., 
2010, Harvey, 2012b). Dysplastic changes of granulo-
cytes (dysgranulopoiesis) include increased numbers 
of myeloblasts, abnormal nuclear shapes (e.g., donut-
shaped nuclei) or multinucleated cells, giant metamy-
elocytes, bands and segmented neutrophils,  matura-
tion arrest, abnormal mitoses, abnormal granulation, 
hyposegmentation or hypersegmentation (Harvey, 
2012b). Most commonly dysgranulopoiesis occurs in 
primary (neoplastic) myelodysplastic syndromes or 
in secondary (nonneoplastic) myelodysplasia in acute 
myeloid neoplasms, in FeLV and/or FIV-infected cats, 
and in various drugs (Harvey, 2012b).
Increased numbers of small lymphocytes, some-
times combined with plasmacytosis, may occur in 
immune-mediated hemolytic anemia in the dog and 
cat and pure red cell aplasia, thymoma, cholangiohep-
atitis and pyrexia of unknown origin in the cat (Weiss, 
2005), in animals with chronic lymphocytic leukemia 
or small cell lymphoma, in which mature-appearing 
lymphocytes exceed 30% of nucleated cells (Figures 
11, a and B) (Workman and Vernau, 2003). Increased 
numbers of medium-sized to large lymphocytes imply 
acute lymphoblastic leukemia or stage V metastatic 
lymphoma (Figure 12) (Harvey, 2012b).  
Benign causes of increased percentages of plas-
ma cells include infectious diseases including canine 
monocytic ehrlichiosis (particularly in the chron-
ic phase of the disease), leishmaniosis (Figure 13) 
and feline infectious peritonitis and frequently the 
immune-mediated hemolytic anemia (Mylonakis et 
al., 2006, Harvey, 2012a). Neoplastic proliferation of 
plasma cells, demonstrating or not morphologic atypia, 
defines multiple myeloma (Figure 14) (Weiss, 2006a). 
abundant mast cells, especially when they 
present atypia and tend to form aggregates are strongly 
suggestive of metastatic mast cell tumor especially in 
the cat (O’Keefe et al., 1987) (Figure 15). Mast cell 
hyperplasia may occur in BM hypoplasia or aplasia 
of various etiologies (e.g., myelosuppressive canine 
monocytic ehrlichiosis) (Mylonakis et al., 2006).
Macrophages may be increased in BM necro-
Figure 12: Canine acute lymphocytic leukemia/large cell 
lymphoma. Large atypical lymphocytes with prominent nucleoli and 
increased mitotic rate efface the bone marrow (modified Wright-
Giemsa, x 200). 
Figure 13: Bone marrow smear from a dog with leishmaniosis 
(Leishmania infantum). Several macrophages with cytoplasmic 
amastigotes of L. infantum (M-Li) are seen.  Small lymphocytes 
(sl) and plasma cells (pc) are also variably present (Giemsa, x1000). 
Figure 14: Bone marrow smear from a dog with multiple myeloma: 
the predominant cell population consists of plasma cells (pc) with 
eccentrically placed nuclei and basophilic cytoplasm  (Giemsa, 
x1000).
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sis, granulomatous inflammation or histiocytic sar-
coma (Weiss, 2006a, Harvey, 2012a). Infectious 
agents may be seen in the cytoplasm of macrophages 
(e.g., L. infantum, E. canis, Histoplasma capsulatum 
(Figure 16), Mycobacterium spp., Cytauxzoon felis) 
(Mylonakis et al., 2003, Saridomichelakis et al., 
2005, Harvey, 2012b).  
Phagocytosis of blood cells and their precursors 
is rare in the BM of healthy animals and generally 
involves only mature erythrocytes (Harvey, 2012b). 
Frequent BM erythrophagocytoses may occur in 
immune-mediated hemolytic anemias, in erythrocytic 
Figure 15: Neoplastic mast cells (arrows) showing no morphologic 
atypia, infiltrating a canine bone marrow. Note the clustering of the 
cells. No circulating mast cells were identified in the examination 
of a peripheral blood film and buffy-coat of this patient (modified 
Wright-Giemsa, x500).
Figure 16: Macrophage containing numerous Histoplasma 
capsulatum organisms (arrow) from an aspirate of canine marrow 
in a patient with disseminated histoplasmosis (modified Wright-
Giemsa, x1000).
Figure 17: Presumptive erythremic myelosis (aML-M6Er) in a dog. 
The combination of light microscopic cytomorphology (blast cells 
with perfectly round nuclei, consistent paranuclear clearing, and 
deeply basophilic cytoplasm devoid of granules) and the negative 
immunophenotyping using antibodies to myeloperoxidase, cluster 
of differentiation (CD) 3, CD79a, CD11b and CD45 were strongly 
suggestive of aML-M6Er (pure erythroid leukemia) (Giemsa, 
x1000). [From: Mylonakis ME et al., (2012) Presumptive pure 
erythroid leukemia in a dog. J Vet Diagn Invest, 24: 1004-1007].
parasites (e.g., Babesia sp., hemoplasmosis), hemat-
opoietic neoplasms, after blood transfusion, and in 
histiocytic neoplasia, including the hemophagocytic 
histiocytosis (Mylonakis et al., 2012), while idiopath-
ic cases have also been reported (Weiss, 2007).
   
BONE MARROW NEOPLASMS
Primary BM malignancies include acute myeloid 
leukemias (aML) (i.e., neoplasms arising from the 
erythrocytic, myelocytic and megakaryocytic series), 
myeloproliferative neoplasms (MPN) (formerly termed 
chronic myeloid leukemias), primary myelodysplas-
tic syndromes (MDS), acute and chronic lymphoid 
leukemias and multiple myeloma (McManus, 2005, 
Juoperi et al., 2011, Harvey, 2012b). Common meta-
static marrow neoplasms include lymphoma, mast 
cell tumor, histiocytic sarcoma and various carcino-
mas (McManus, 2005, Raskin and Messick, 2012). 
The presence of blast cells in the BM in excess of 
20% of all nucleated cells (aNC) is strongly sug-
gestive of acute myeloid leukemia (Figures 17 and 
18), if an exaggerated hyperplastic response has been 
ruled out (Harvey, 2012b, Raskin and Messick, 2012, 
Grindem et al., 2014). according to the classification 
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established by the american Society for Veterinary 
Clinical Pathology animal Leukemia study Group, 
canine and feline acute myeloid leukemias include 
aML-M1 (myeloblastic leukemia without matura-
tion), aML-M2 (myeloblastic leukemia with matura-
tion), aML-M4 (myelomonocytic leukemia), aML-
M5 (monocytic leukemia), aML-M6 (erythroleuke-
mia) or aML-M6Er (erythremic myelosis), aML-M7 
(megakaryocytic leukemia) and acute undifferentiated 
leukemia (Jain et al., 1991, McManus 2005). Blast 
cells less that 20% of aNC indicate MPN or pri-
mary MDS (McManus, 2005). Myeloproliferative 
neoplasms include chronic myeloid leukemia, eosi-
nophilic leukemia, basophilic leukemia, prima-
ry erythrocytosis and essential thrombocythemia 
(Harvey, 2012b). In MDS more than 10% of the cells 
in one or more BM cell lineages demonstrate dysplas-
tic changes (Weiss and aird, 2001, Weiss, 2006b, 
Harvey, 2012b). In dogs and cats MDS have been 
classified in three subtypes, namely MDS with eryth-
roid predominance (MDS-Er, M/E<1, blasts<20% 
aNC), myelodysplastic syndrome refractory cytope-
nias (MDS-RC, M/E>1, blasts<5% aNC) and mye-
lodysplastic syndrome-excess blasts (MDS-EB, M/
E>1, blasts 5-19% aNC) (McManus, 2005, Harvey, 
Figure 18: acute myeloid leukemia in a FeLV-infected cat. a 
diagnosis of acute myelomonocytic leukemia (aML-M4) was 
made on the basis of the results of bone marrow cytology (blast 
cell percentage in excess of 20% of all nucleated cells) and 
immunochemistry (cluster of differentiation (CD) 3 and CD79a 
negative, positive for lysozyme, and myeloperoxidase) tests 
(Giemsa, x1000). [From: Mylonakis ME et al., (2008) acute 
myelomonocytic leukaemia with short-term spontaneous remission 
in a cat. aust Vet J, 86: 224-228]. 
Figure 19: Presumptive histiocytic sarcoma in a persistently 
anemic cat. Bone marrow aspirate smears were predominated by 
a monomorphic population of individual or aggregated round-
to-oval cells, likely of histiocytic origin that often phagocytosed 
erythrocytes (arrows) and leukocytes. These features were also 
demonstrated in spleen aspirates (not shown) (Giemsa, x400). 
[From: Mylonakis ME et al., (2012) Presumptive histiocytic 
neoplasm with unusual immunophenotype in a cat. Comp Clin 
Pathol, 21: 231-236]. 
2012b). Dogs and cats with MDS are prone to develop 
aML or lymphoid neoplasms (Harvey, 2012b). Mature 
lymphocytes or lymphoblasts in excess of 30% of 
aNC support the diagnosis of chronic lymphocytic 
or acute lymphoblastic leukemia, respectively, pro-
vided that a metastatic lymphoma has been ruled out 
(Workman and Vernau, 2003). The diagnosis of mul-
tiple myeloma (Figure 14) is highly suggestive if 15% 
or more plasma cells occur in the BM (Harvey, 2012b). 
Large cohesive cell clusters are usually associated with 
metastatic mast cell tumor, histiocytic sarcoma (Figure 
19) or carcinomas (Grindem et al., 2014).
CONCLUDING REMARKS 
Bone marrow aspiration cytology is a cost-
effective diagnostic tool, which provides excellent 
morphological detail of cells and infectious agents. 
Complications associated with BM aspiration are rare 
and the equipment required minimal, which account 
for the popularity of this procedure in the clinical set-
ting of companion animal medicine.
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